bioMérieux VITEK PRO receives FDA clearance and IVDR CE marking

bioMérieux has announced US FDA 510(k) clearance and CE marking under the IVDR for VITEK PRO, a new automated system for microbial identification and antimicrobial susceptibility testing (ID/AST).

The company says a single platform identifies the organism behind an infection and shows which antibiotics it responds to, supporting antimicrobial stewardship. Launch is planned from the first quarter of 2027 in the United States and some European countries, with wider roll-out from the second quarter of 2027 as the successor to VITEK 2 and VITEK XL.

Source: bioMérieux
Date: 10 November 2026
Original: https://www.biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2026/press-releases/PR_bioMerieux_VITEK-PRO_FDA-Clearance_20261110.pdf